IMVAMUNE
Google image searchProduct monograph
Active ingredient
modified vaccinia virus (ankara-bavarian nordic), 50000000 CCID50/0.5 ML
DIN: 02416638
Dosage form(s): SUSPENSION
Route(s) of administration: SUBCUTANEOUS
Description: MODIFIED VACCINIA VIRUS, LIVE, ATTENUATED, NON REPLICATING. 20X0.5ML SINGLE-DOSE VIALS
Schedule: Schedule D
Company: BAVARIAN NORDIC AS
Date: 29-MAY-2023
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07B — VIRAL VACCINES (ATC, ATC/DDD)
- J07BX — Other viral vaccines (ATC, ATC/DDD)
- J07BX01 — SMALLPOX AND MONKEYPOX VACCINES (ATC/DDD)
